Effect of maternal calcium intake during pregnancy on children's blood pressure: A systematic review of the literature

Background  

Calcium supplementation during pregnancy has been shown to reduce the incidence of hypertension in the mother, but the effects on the offspring are uncertain. Assessing the impact on the offspring is very important given the now large body of evidence indicating that blood pressure levels in childhood and young adulthood can be influenced by factors operating during fetal life. We conducted a systematic review of the literature to summarize the evidence supporting an association between maternal dietary calcium intake during pregnancy and blood pressure in the offspring.     

Duration of response to intramuscular versus low dose intradermal hepatitis B booster immunization

OBJECTIVE: To determine the duration of the immune response to plasma-derived hepatitis B vaccine among healthcare workers responding to booster doses of intradermal (ID) or intramuscular (IM) vaccine in 1986 and those with protective levels of antibody to hepatitis B surface antigen (anti-HBs) in 1986 without booster vaccine. Both groups received a primary hepatitis B vaccine series 24 to 36 months earlier. DESIGN: Cross-sectional follow-up study two years later of an inception cohort defined in 1986. SETTING: An academically affiliated metropolitan county hospital. PARTICIPANTS: Group 1: Hospital employees responding to booster doses of hepatitis B vaccine given ID or IM in 1986 due to low anti-HBs levels. Forty-one (82%) of 50 eligible persons were evaluated. Group 2: Persons not receiving booster vaccine in 1986 due to protective levels of anti-HBs. A random sample of 95 persons was drawn from a pool of 152 participants with protective levels in 1986. Sixty-five (68%) of 95 contacted persons were restudied. RESULTS: In 1988, 14 (64%) of 22 previous ID responders had anti-HBs levels greater than or equal to 10 milli-international units (mIU)/mL, compared with 17 (89%) of 19 IM responders (p = .055). The 1988 geometric mean titer of IM recipients was 66.4 +/- 4.5 mIU/mL and of ID recipients was 20.7 +/- 7.4 (p = .04). None of 65 Group 2 subjects' anti-HBs titers dropped below 10 mIU/mL by 1988. CONCLUSIONS: Plasma-derived hepatitis B vaccine recipients with anti-HBs levels greater than or equal to 10 mIU/mL at 24 to 36 months after primary immunization are likely to maintain these levels two years later. The diminished durability of the antibody response together with the increased rate of local side effects associated with the ID injection route may limit its applicability as an alternative to using IM booster doses of hepatitis B vaccine.     

Cutaneous lymphoid hyperplasia: results of radiation therapy

Four cases of cutaneous lymphoid hyperplasia (CLH) were treated with radiation therapy. Sixteen separate areas of the skin were irradiated. Only two received more than 18 Gy (1,800 rad). Follow-up ranged from eight months to seven years. No infield recurrences were observed, and cosmetic results were excellent. The authors suggest that radiation therapy can be highly effective in the treatment of CLH.     

The Inter-Regional Epidemiological Study of Childhood Cancer (IRESCO). Study design, control selection and data collection

The Inter-Regional Epidemiological Study of Childhood Cancer (IRESCC) was established to investigate the role of possible aetiological factors in childhood cancer, with particular emphasis on environmental exposures to the foetus and family history of certain diseases including cancer. Incident cases occurring in three Health Service regions (the West Midlands, Yorkshire and North Western) were matched for age and sex with two sets of control children. A total of 555 cases and 1110 controls were entered into the study. The parents of each index child were interviewed with respect to events during the relevant pregnancy, occupation, smoking habits, and past medical history of themselves, the child's siblings and other relatives. Ninety-three per cent of case parents approached agreed to be interviewed, and approximately 90% of controls were ranked first or second on the control selection lists. After the interview information was verified by reference to antenatal and other medical records. Obstetric and general practitioner records were abstracted for approximately 90% of cases and controls. Information derived from the interview and that from medical records was coded separately. The data collected by each region have been pooled and case-control comparisons of potential aetiological factors will be carried out, using matched triplet analyses.     

Role of chest CT in non-Hodgkin lymphoma

A retrospective study of 48 patients with non-Hodgkin lymphoma (NHL) who underwent 54 computed tomographic (CT) examinations of the chest evaluated the role of chest CT in the management of this disease. Of 18 cases in which chest radiographs were not indicative of NHL, CT scans showed abnormalities consistent with NHL in five (28%). Of 11 cases where radiographs were questionable, CT confirmed NHL in five (45%) and excluded it in six (55%). Of 25 cases where radiographs were consistent with NHL, CT confirmed the findings in 23 (92%) and added information in all 25. Chest CT affected management in eight of 25 treated and five of 19 untreated patients. It appears to be useful in untreated patients with stage I or II NHL but no definite radiographic abnormalities, or with abnormal radiographs but no extrathoracic spread, and in treated patients with questionable radiographs. CT is not helpful in untreated patients with stage III or IV NHL or treated patients with normal radiographs.